Newsfile Corp
20 Jul 2026, 01:15 UTC · 20h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
GeneDx cut its 2026 revenue guidance from $540-555 million down to $475-490 million. — A significant reduction in forward-looking revenue guidance directly lowers valuation and signals deteriorating business momentum.
-0.80GeneDx took a $31.3 million goodwill impairment charge on the Fabric Genomics acquisition, which was purchased for $36.5 million only one year prior. — Wiping out nearly 85% of an acquisition's value within one year indicates a major strategic failure and a significant loss of assets.
-0.70GeneDx's average reimbursement rates were $3,300, which was $200 below market expectations. — Lower-than-expected reimbursement rates directly compress gross margins and indicate pricing pressure in the core business.
-0.50Continue reading
6 related stories
Top 2 movers · tap to explore
GeneDx is facing a federal securities class action lawsuit alleging false and misleading statements regarding its operations and the Fabric Genomics acquisition. — Class action litigation creates legal overhang and potential future cash settlements, though it follows the initial price crash.
-0.40Which stocks this story touches
The company is facing a federal securities class action lawsuit following a 49% share price drop, revenue guidance cuts, and significant goodwill impairment charges.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
3h ago
